H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 18.52 HKD 1.42% Market Closed
Market Cap: 109.9B HKD
Have any thoughts about
Hansoh Pharmaceutical Group Company Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Hansoh Pharmaceutical Group Company Ltd

Wall Street analysts forecast Hansoh Pharmaceutical Group Company Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hansoh Pharmaceutical Group Company Ltd is 23.91 HKD with a low forecast of 18.13 HKD and a high forecast of 31.5 HKD.

Lowest
Price Target
18.13 HKD
2% Downside
Average
Price Target
23.91 HKD
29% Upside
Highest
Price Target
31.5 HKD
70% Upside
Hansoh Pharmaceutical Group Company Ltd Competitors:
Price Targets
TORNTPHARM
Torrent Pharmaceuticals Ltd
12% Upside
600380
Joincare Pharmaceutical Group Industry Co Ltd
25% Upside
SECARE
Swedencare AB (publ)
33% Upside
4530
Hisamitsu Pharmaceutical Co Inc
7% Upside
4568
Daiichi Sankyo Co Ltd
48% Upside
002294
Shenzhen Salubris Pharmaceuticals Co Ltd
3% Upside
OGI
OrganiGram Holdings Inc
76% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Hansoh Pharmaceutical Group Company Ltd

For the last 6 years the compound annual growth rate for Hansoh Pharmaceutical Group Company Ltd's revenue is 9%. The projected CAGR for the next 3 years is 12%.

9%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hansoh Pharmaceutical Group Company Ltd

For the last 6 years the compound annual growth rate for Hansoh Pharmaceutical Group Company Ltd's operating income is 6%. The projected CAGR for the next 3 years is 19%.

6%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Hansoh Pharmaceutical Group Company Ltd

For the last 6 years the compound annual growth rate for Hansoh Pharmaceutical Group Company Ltd's net income is 13%. The projected CAGR for the next 3 years is 10%.

13%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hansoh Pharmaceutical Group Company Ltd's stock price target?
Price Target
23.91 HKD

According to Wall Street analysts, the average 1-year price target for Hansoh Pharmaceutical Group Company Ltd is 23.91 HKD with a low forecast of 18.13 HKD and a high forecast of 31.5 HKD.

What is Hansoh Pharmaceutical Group Company Ltd's Revenue forecast?
Projected CAGR
12%

For the last 6 years the compound annual growth rate for Hansoh Pharmaceutical Group Company Ltd's revenue is 9%. The projected CAGR for the next 3 years is 12%.

What is Hansoh Pharmaceutical Group Company Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 6 years the compound annual growth rate for Hansoh Pharmaceutical Group Company Ltd's operating income is 6%. The projected CAGR for the next 3 years is 19%.

What is Hansoh Pharmaceutical Group Company Ltd's Net Income forecast?
Projected CAGR
10%

For the last 6 years the compound annual growth rate for Hansoh Pharmaceutical Group Company Ltd's net income is 13%. The projected CAGR for the next 3 years is 10%.

Back to Top